Paper Tigers Or Paper Bullets? FDA Cutting Down On Repeat GMP Warnings
This article was originally published in The Tan Sheet
Executive Summary
FDA enforcement policies being carried out by the Office of the Chief Counsel could eliminate the practice of issuing multiple manufacturing compliance warning letters
You may also be interested in...
Warning Letter Review By FDA Chief Counsel’s Office Will Take Five Days
FDA's Office of Chief Counsel will have five working days to review warning letters that previously were sent directly to manufacturers from district offices
Allen, Azar & Troy: FDA Legal Partners Streamline Enforcement Activity
HHS' decision to elevate FDA warning letter oversight from the Office of Regulatory Affairs to the Office of the Chief Counsel signals an attempt to keep a tighter rein on the agency in the absence of a commissioner
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC